A&O advising Goldman Sachs Asset Management Division on the financing of its acquisition of Norgine
Related people
Headlines in this article
Related news and insights
Publications: 04 April 2024
Publications: 03 April 2024
Chief Information Security Officers and cyber whistleblowing: considerations for PE firms
Publications: 03 April 2024
News: 26 March 2024
A&O advises CVC on the financing of its investment in Monbake
Allen & Overy has advised Goldman Sachs Asset Management Division on the financing for its acquisition of a controlling stake in leading European specialty pharmaceuticals company Norgine BV. The financing was awarded "EMEA Private Debt Loan of the Year" at the IFR Awards 2022.
Norgine has over 1,500 employees, with a presence in 16 European countries as well as Australia and New Zealand. Norgine has brought transformative medicines to patients for over a century.
The A&O team was led by partners Vanessa Xu, Robin Harvey and senior associate Nick Hallam, supported by associate Ramone Bedi.
High yield partner John Kicken and associate Sampada Bannurmath also advised on the transaction.